About FasT Biopharma
FasT Biopharma is a biotechnology company specializing in immuno-oncology (IO). It develops therapeutic antibodies designed to address new targets in immuno-oncology. It's lead product is an optimized antibody against a key IO target. It is based in Oxfordshire, England.
Missing: FasT Biopharma's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: FasT Biopharma's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
FasT Biopharma Frequently Asked Questions (FAQ)
Where is FasT Biopharma's headquarters?
FasT Biopharma's headquarters is located at 10 Aston Park, Oxfordshire.
What is FasT Biopharma's latest funding round?
FasT Biopharma's latest funding round is Other Investors.
Who are the investors of FasT Biopharma?
Investors of FasT Biopharma include Alderley Park Ventures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.